Biblioteca Humberto Rosselli Quijano
Journal of Clinical Psychopharmacology / Rothschild, Anthony J. . Año 2004 - Vol. 24 - No. 1Mención de fecha: Febrero Fecha de aparición: 30/11/2023 |
[número]
[número]
Año 2004 - Vol. 24 - No. 1 - Febrero - Journal of Clínical Psychopharmacology [texto impreso] / Richard I. Shader, Editor científico ; David J. Greenblatt, Editor científico . - 2023 . - pp. 1-112 : Cuadros, gráficas ; 28 cm. ISSN : 0271-0749 Idioma : Inglés (eng) Idioma original : Inglés (eng) |
Ejemplares (1)
Código de barras | Signatura | Tipo de medio | Ubicación | Sección | Estado |
---|---|---|---|---|---|
100255 | Journal of Clinical Psychopharmacology | Publicaciones seriadas | Biblioteca Instituto Colombiano del Sistema Nervioso | Hemeroteca | Disponible |
Artículos
Añadir el resultado a su cestaComparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers / C. Lindsay DeVane en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers Tipo de documento: texto impreso Autores: C. Lindsay DeVane, Autor ; Jennifer L. Donovan, Autor ; Heidi L. Liston, Autor Fecha de publicación: 2023 Artículo en la página: pp. 4-10 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Radioisótopos de carbono, Ciclohexanoles, Inhibidores de la enzima citocromo P-450, Sistema enzimático citocromo P-450, Eritromicina, Fluoxetina, Piperazinas, Sertralina. Resumen: An antidepressant for use in the patient receiving concomitant drug treatment, over-the-counter medications, or herbal products should lack cytochrome P-450 (CYP) 3A4 inductive or inhibitory activity to provide the least likelihood of a drug-drug interaction. This study addresses the potential of 4 diverse antidepressants (venlafaxine, nefazodone, sertraline, and fluoxetine) to inhibit or induce CYP3A4. Link: ./index.php?lvl=notice_display&id=30971
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 4-10[artículo] Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers [texto impreso] / C. Lindsay DeVane, Autor ; Jennifer L. Donovan, Autor ; Heidi L. Liston, Autor . - 2023 . - pp. 4-10.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 4-10
Palabras clave: Radioisótopos de carbono, Ciclohexanoles, Inhibidores de la enzima citocromo P-450, Sistema enzimático citocromo P-450, Eritromicina, Fluoxetina, Piperazinas, Sertralina. Resumen: An antidepressant for use in the patient receiving concomitant drug treatment, over-the-counter medications, or herbal products should lack cytochrome P-450 (CYP) 3A4 inductive or inhibitory activity to provide the least likelihood of a drug-drug interaction. This study addresses the potential of 4 diverse antidepressants (venlafaxine, nefazodone, sertraline, and fluoxetine) to inhibit or induce CYP3A4. Link: ./index.php?lvl=notice_display&id=30971 Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment / Koji Shinkai en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment Tipo de documento: texto impreso Autores: Koji Shinkai, Autor ; Reiji Yoshimura, Autor ; Nobuhisa Ueda, Autor Fecha de publicación: 2023 Artículo en la página: pp. 11-17 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Biomarcadores, Ciclopropanos, Trastorno Depresivo, Metoxihidroxifenilglicol, Paroxetina. Resumen: The purpose of this study was to investigate the effects of milnacipran and paroxetine on plasma levels of catecholamine metabolites, and we attempted to elucidate the differences between the mechanisms of these drugs in catecholaminergic neurons. In depressed patients, we investigated the relationships among pretreatment levels of catecholamine metabolites, the changes in plasma catecholamine metabolite levels before and after administration of milnacipran or paroxetine, and clinical response to these drugs. Link: ./index.php?lvl=notice_display&id=30972
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 11-17[artículo] Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment [texto impreso] / Koji Shinkai, Autor ; Reiji Yoshimura, Autor ; Nobuhisa Ueda, Autor . - 2023 . - pp. 11-17.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 11-17
Palabras clave: Biomarcadores, Ciclopropanos, Trastorno Depresivo, Metoxihidroxifenilglicol, Paroxetina. Resumen: The purpose of this study was to investigate the effects of milnacipran and paroxetine on plasma levels of catecholamine metabolites, and we attempted to elucidate the differences between the mechanisms of these drugs in catecholaminergic neurons. In depressed patients, we investigated the relationships among pretreatment levels of catecholamine metabolites, the changes in plasma catecholamine metabolite levels before and after administration of milnacipran or paroxetine, and clinical response to these drugs. Link: ./index.php?lvl=notice_display&id=30972 Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder / Richard Delorme en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder Tipo de documento: texto impreso Autores: Richard Delorme, Autor ; Nadia Chabane, Autor ; Jacques Callebert, Autor Fecha de publicación: 2023 Artículo en la página: pp. 18-23 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Imipramina, Fosfatos de inositol, Isótopos de yodo, Dietilamida del ácido lisérgico, Glicoproteínas de membrana, Trastorno Obsesivo-Compulsivo, Trastorno obsesivo-compulsivo, Paroxetina, Receptor de serotonina 5-HT2A, Inhibidores selectivos de la recaptación de serotonina. Resumen: Serotonin reuptake inhibitors (SRIs) are the most efficient pharmacological treatment of obsessive-compulsive disorders (OCD). Previous studies have suggested that some peripheral serotonergic parameters can be used to predict the clinical outcome of the treatment of OCD patients with SRIs. We tried to identify further peripheral serotonergic parameters that could help predict the clinical outcome of SRI treatment in a sample of patients with OCD. Link: ./index.php?lvl=notice_display&id=30973
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 18-23[artículo] Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder [texto impreso] / Richard Delorme, Autor ; Nadia Chabane, Autor ; Jacques Callebert, Autor . - 2023 . - pp. 18-23.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 18-23
Palabras clave: Imipramina, Fosfatos de inositol, Isótopos de yodo, Dietilamida del ácido lisérgico, Glicoproteínas de membrana, Trastorno Obsesivo-Compulsivo, Trastorno obsesivo-compulsivo, Paroxetina, Receptor de serotonina 5-HT2A, Inhibidores selectivos de la recaptación de serotonina. Resumen: Serotonin reuptake inhibitors (SRIs) are the most efficient pharmacological treatment of obsessive-compulsive disorders (OCD). Previous studies have suggested that some peripheral serotonergic parameters can be used to predict the clinical outcome of the treatment of OCD patients with SRIs. We tried to identify further peripheral serotonergic parameters that could help predict the clinical outcome of SRI treatment in a sample of patients with OCD. Link: ./index.php?lvl=notice_display&id=30973 Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder / Stephen V. Faraone en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder Tipo de documento: texto impreso Autores: Stephen V. Faraone, Autor ; Thomas J. Spencer, Autor ; Megan Aleardi, Autor Fecha de publicación: 2023 Artículo en la página: pp. 24-29 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno de Déficit de Atención con Hiperactividad, Metilfenidato - uso terapéutico Resumen: This article reviews the efficacy of methylphenidate (MPH) for adult attention-deficit/hyperactivity disorder (ADHD). A literature search identified double-blind placebo-controlled MPH treatment studies of ADHD adults. Meta-analysis estimated the pooled effect size for MPH treatment and tested for publication bias. Meta-analysis regression assessed the influence of study design features on medication effects. Link: ./index.php?lvl=notice_display&id=30974
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 24-29[artículo] Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder [texto impreso] / Stephen V. Faraone, Autor ; Thomas J. Spencer, Autor ; Megan Aleardi, Autor . - 2023 . - pp. 24-29.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 24-29
Palabras clave: Trastorno de Déficit de Atención con Hiperactividad, Metilfenidato - uso terapéutico Resumen: This article reviews the efficacy of methylphenidate (MPH) for adult attention-deficit/hyperactivity disorder (ADHD). A literature search identified double-blind placebo-controlled MPH treatment studies of ADHD adults. Meta-analysis estimated the pooled effect size for MPH treatment and tested for publication bias. Meta-analysis regression assessed the influence of study design features on medication effects. Link: ./index.php?lvl=notice_display&id=30974 Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder / Joachim F. Wernicke en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder : A prospective, placebo-controlled assessment Tipo de documento: texto impreso Autores: Joachim F. Wernicke, Autor ; Lenard Adler, Autor ; Thomas J. Spencer, Autor Fecha de publicación: 2023 Artículo en la página: pp. 30-35 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno por Déficit de Atención con Hiperactividad, Propilaminas, Índice de gravedad de la enfermedad Resumen: Drugs that affect neurotransmitter release can induce changes in neuroregulation during chronic administration. Thus, in addition to recurrence of symptoms of the illness, discontinuation of treatment can be associated with clinical signs and symptoms related to these changes. Atomoxetine, a new drug approved in the United States for treatment of attention deficit/hyperactivity disorder (ADHD), is associated with blockade of the presynaptic norepinephrine transporter. Link: ./index.php?lvl=notice_display&id=30975
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 30-35[artículo] Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder : A prospective, placebo-controlled assessment [texto impreso] / Joachim F. Wernicke, Autor ; Lenard Adler, Autor ; Thomas J. Spencer, Autor . - 2023 . - pp. 30-35.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 30-35
Palabras clave: Trastorno por Déficit de Atención con Hiperactividad, Propilaminas, Índice de gravedad de la enfermedad Resumen: Drugs that affect neurotransmitter release can induce changes in neuroregulation during chronic administration. Thus, in addition to recurrence of symptoms of the illness, discontinuation of treatment can be associated with clinical signs and symptoms related to these changes. Atomoxetine, a new drug approved in the United States for treatment of attention deficit/hyperactivity disorder (ADHD), is associated with blockade of the presynaptic norepinephrine transporter. Link: ./index.php?lvl=notice_display&id=30975 Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder / Timothy E. Wilens en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder : Results from a one-year follow-up study Tipo de documento: texto impreso Autores: Timothy E. Wilens, Autor ; Joseph Biederman, Autor ; Marc Lerner, Autor Fecha de publicación: 2023 Artículo en la página: pp. 36-41 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno de Déficit de Atención con Hiperactividad, Preparaciones de acción retardada, Frecuencia cardíaca. Resumen: Studies of vital signs in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) receiving stimulants indicate a variable effect on blood pressure (BP) and heart rate (HR). We evaluated the longer-term effects on vital signs of once-daily osmotic-release methylphenidate (MPH, Concerta) in children with ADHD. Link: ./index.php?lvl=notice_display&id=30976
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 36-41[artículo] Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder : Results from a one-year follow-up study [texto impreso] / Timothy E. Wilens, Autor ; Joseph Biederman, Autor ; Marc Lerner, Autor . - 2023 . - pp. 36-41.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 36-41
Palabras clave: Trastorno de Déficit de Atención con Hiperactividad, Preparaciones de acción retardada, Frecuencia cardíaca. Resumen: Studies of vital signs in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) receiving stimulants indicate a variable effect on blood pressure (BP) and heart rate (HR). We evaluated the longer-term effects on vital signs of once-daily osmotic-release methylphenidate (MPH, Concerta) in children with ADHD. Link: ./index.php?lvl=notice_display&id=30976 Predictors of response in generalized social phobia / Michael Van Ameringen en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Predictors of response in generalized social phobia : Effect of age of onset Tipo de documento: texto impreso Autores: Michael Van Ameringen, Autor ; Jonathan Oakman, Autor ; Catherine Mancini, Autor Fecha de publicación: 2023 Artículo en la página: pp. 42-48 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos fóbicos, Ensayos controlados aleatorios, Sertralina, Índice de gravedad de la enfermedad. Resumen: Selective serotonin reuptake inhibitors (SSRIs) are the gold standard for the pharmacological treatment of generalized social phobia (GSP). However, little is known about the predictors of response to treatment. Two hundred and four outpatients with GSP were randomized to sertraline (Zoloft) or placebo, for a 20-week double-blind study, with a flexible dose range of sertraline 50 to 200 mg/d. Link: ./index.php?lvl=notice_display&id=30977
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 42-48[artículo] Predictors of response in generalized social phobia : Effect of age of onset [texto impreso] / Michael Van Ameringen, Autor ; Jonathan Oakman, Autor ; Catherine Mancini, Autor . - 2023 . - pp. 42-48.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 42-48
Palabras clave: Trastornos fóbicos, Ensayos controlados aleatorios, Sertralina, Índice de gravedad de la enfermedad. Resumen: Selective serotonin reuptake inhibitors (SSRIs) are the gold standard for the pharmacological treatment of generalized social phobia (GSP). However, little is known about the predictors of response to treatment. Two hundred and four outpatients with GSP were randomized to sertraline (Zoloft) or placebo, for a 20-week double-blind study, with a flexible dose range of sertraline 50 to 200 mg/d. Link: ./index.php?lvl=notice_display&id=30977 A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder / H.G.M. Westenberg en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder Tipo de documento: texto impreso Autores: H.G.M. Westenberg, Autor ; Dan J. Stein, Autor ; Haichen Yang, Autor Fecha de publicación: 2023 Artículo en la página: pp. 49-55 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos de ansiedad, Preparados de acción retardada, Preparaciones de acción retardada, Fluvoxamina. Resumen: This was a randomized double-blind placebo-controlled multicenter study to assess the efficacy, safety, and tolerability of fluvoxamine in a controlled release (CR) formulation for treatment of generalized social anxiety disorder (GSAD). A total of 300 subjects with GSAD were randomly assigned to receive either fluvoxamine CR (N = 149) or placebo (N = 151) for 12 weeks. Link: ./index.php?lvl=notice_display&id=30978
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 49-55[artículo] A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder [texto impreso] / H.G.M. Westenberg, Autor ; Dan J. Stein, Autor ; Haichen Yang, Autor . - 2023 . - pp. 49-55.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 49-55
Palabras clave: Trastornos de ansiedad, Preparados de acción retardada, Preparaciones de acción retardada, Fluvoxamina. Resumen: This was a randomized double-blind placebo-controlled multicenter study to assess the efficacy, safety, and tolerability of fluvoxamine in a controlled release (CR) formulation for treatment of generalized social anxiety disorder (GSAD). A total of 300 subjects with GSAD were randomly assigned to receive either fluvoxamine CR (N = 149) or placebo (N = 151) for 12 weeks. Link: ./index.php?lvl=notice_display&id=30978 A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning / Rikus Knegtering en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning Tipo de documento: texto impreso Autores: Rikus Knegtering, Autor ; Stynke Castelein, Autor ; Han Bous, Autor Fecha de publicación: 2023 Artículo en la página: pp. 56-61 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona. Resumen: To compare sexual functioning in patients treated with quetiapine or risperidone.
This open-label study included patients with schizophrenia or a related psychotic illness who were randomized to quetiapine (200-1200 mg/d) or risperidone (1-6 mg/d) for 6 weeks. Sexual dysfunction was assessed by a semistructured interview, the Antipsychotics and Sexual Functioning Questionnaire (ASFQ), based upon the Utvalg for Kliniske Undersogelser (UKU).Link: ./index.php?lvl=notice_display&id=30979
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 56-61[artículo] A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning [texto impreso] / Rikus Knegtering, Autor ; Stynke Castelein, Autor ; Han Bous, Autor . - 2023 . - pp. 56-61.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 56-61
Palabras clave: Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona. Resumen: To compare sexual functioning in patients treated with quetiapine or risperidone.
This open-label study included patients with schizophrenia or a related psychotic illness who were randomized to quetiapine (200-1200 mg/d) or risperidone (1-6 mg/d) for 6 weeks. Sexual dysfunction was assessed by a semistructured interview, the Antipsychotics and Sexual Functioning Questionnaire (ASFQ), based upon the Utvalg for Kliniske Undersogelser (UKU).Link: ./index.php?lvl=notice_display&id=30979 A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition / Edmund P. Harrigan en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition Tipo de documento: texto impreso Autores: Edmund P. Harrigan, Autor ; Jeffrey J. Miceli, Autor ; Richard Anziano, Autor Fecha de publicación: 2023 Artículo en la página: pp. 62-69 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Aril Hidrocarburo Hidroxilasas, Benzodiazepinas, Clozapina, Dibenzotiazepinas, Electrocardiografía, Haloperidol, Sistema de conducción del corazón, Síndrome de QT largo, Olanzapina, Fumarato de quetiapina, Risperidona, Tioridazina. Resumen: Many drugs have been associated with QTc prolongation and, in some cases, this is augmented by concomitant administration with metabolic inhibitors. The effects of 6 antipsychotics on the QTc interval at and around the time of estimated peak plasma/serum concentrations in the absence and presence of metabolic inhibition were characterized in a prospective, randomized study in which patients with psychotic disorders reached steady-state on either haloperidol 15 mg/d (n = 27), thioridazine 300 mg/d (n = 30), ziprasidone 160 mg/d (n = 31), quetiapine 750 mg/d (n = 27), olanzapine 20 mg/d (n = 24), or risperidone 6-8 mg/d increased to 16 mg/d (n = 25/20). Link: ./index.php?lvl=notice_display&id=30980
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 62-69[artículo] A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition [texto impreso] / Edmund P. Harrigan, Autor ; Jeffrey J. Miceli, Autor ; Richard Anziano, Autor . - 2023 . - pp. 62-69.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 62-69
Palabras clave: Antipsicóticos, Aril Hidrocarburo Hidroxilasas, Benzodiazepinas, Clozapina, Dibenzotiazepinas, Electrocardiografía, Haloperidol, Sistema de conducción del corazón, Síndrome de QT largo, Olanzapina, Fumarato de quetiapina, Risperidona, Tioridazina. Resumen: Many drugs have been associated with QTc prolongation and, in some cases, this is augmented by concomitant administration with metabolic inhibitors. The effects of 6 antipsychotics on the QTc interval at and around the time of estimated peak plasma/serum concentrations in the absence and presence of metabolic inhibition were characterized in a prospective, randomized study in which patients with psychotic disorders reached steady-state on either haloperidol 15 mg/d (n = 27), thioridazine 300 mg/d (n = 30), ziprasidone 160 mg/d (n = 31), quetiapine 750 mg/d (n = 27), olanzapine 20 mg/d (n = 24), or risperidone 6-8 mg/d increased to 16 mg/d (n = 25/20). Link: ./index.php?lvl=notice_display&id=30980 Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients / Amin Rostami Hodjegan en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)
[artículo]
Título : Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients Tipo de documento: texto impreso Autores: Amin Rostami Hodjegan, Autor ; Ajmal M. Amin, Autor ; Edgar P. Spencer, Autor Fecha de publicación: 2023 Artículo en la página: pp. 70-78 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Envejecimiento, Peso corporal, Clozapina, Relación dosis-respuesta, Modelos Biológicos, Cumplimiento del paciente, Tabaquismo - metabolismo Resumen: The measurement of plasma clozapine concentrations is useful in assessing compliance, optimizing therapy, and minimizing toxicity.
We measured plasma clozapine and norclozapine (N-desmethylclozapine) concentrations in samples from 3782 patients (2648 male, 1127 female). No clozapine was detected in 291 samples (227 patients, median prescribed dose 300 mg/d).Link: ./index.php?lvl=notice_display&id=30981
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 70-78[artículo] Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients [texto impreso] / Amin Rostami Hodjegan, Autor ; Ajmal M. Amin, Autor ; Edgar P. Spencer, Autor . - 2023 . - pp. 70-78.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 70-78
Palabras clave: Envejecimiento, Peso corporal, Clozapina, Relación dosis-respuesta, Modelos Biológicos, Cumplimiento del paciente, Tabaquismo - metabolismo Resumen: The measurement of plasma clozapine concentrations is useful in assessing compliance, optimizing therapy, and minimizing toxicity.
We measured plasma clozapine and norclozapine (N-desmethylclozapine) concentrations in samples from 3782 patients (2648 male, 1127 female). No clozapine was detected in 291 samples (227 patients, median prescribed dose 300 mg/d).Link: ./index.php?lvl=notice_display&id=30981